KLP Kapitalforvaltning AS purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 19,600 shares of the company's stock, valued at approximately $383,000.
A number of other large investors have also recently modified their holdings of the company. First Horizon Advisors Inc. raised its position in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after buying an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group in the fourth quarter valued at about $51,000. Quarry LP lifted its stake in Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after acquiring an additional 2,533 shares during the period. Finally, Neo Ivy Capital Management bought a new position in Privia Health Group during the 3rd quarter worth about $66,000. Hedge funds and other institutional investors own 94.48% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have recently commented on PRVA. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Needham & Company LLC restated a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a report on Friday, March 21st. Stephens reiterated an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Macquarie assumed coverage on Privia Health Group in a research note on Monday, December 16th. They set an "outperform" rating and a $25.00 price objective for the company. Finally, JMP Securities set a $29.00 price objective on Privia Health Group in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $26.67.
Get Our Latest Research Report on PRVA
Privia Health Group Trading Up 6.0 %
Shares of NASDAQ PRVA traded up $1.31 during midday trading on Wednesday, reaching $23.05. The company had a trading volume of 1,524,114 shares, compared to its average volume of 785,943. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04. The business's 50-day simple moving average is $23.73 and its 200 day simple moving average is $21.41. The stock has a market cap of $2.78 billion, a P/E ratio of 230.52, a P/E/G ratio of 3.47 and a beta of 0.88.
Insider Activity at Privia Health Group
In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 14.20% of the stock is owned by insiders.
Privia Health Group Company Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
